# Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis

> **NCT02048644** · PHASE2 · COMPLETED · sponsor: **Hull University Teaching Hospitals NHS Trust** · enrollment: 20 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** fostair
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02048644
- **Lead sponsor:** Hull University Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-04
- **Final completion:** 2015-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02048644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02048644, "Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02048644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*